JHS Svendgaard Laboratories Limited
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades in, and sells a range of oral and dental products in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, whitening gels, talcum powders, sanitizers, detergents, and denture tablets. It also provides contract manufacturing services for oral care products. In ad… Read more
JHS Svendgaard Laboratories Limited (JHS) - Net Assets
Latest net assets as of September 2025: ₹1.74 Billion INR
Based on the latest financial reports, JHS Svendgaard Laboratories Limited (JHS) has net assets worth ₹1.74 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹2.07 Billion) and total liabilities (₹332.52 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹1.74 Billion |
| % of Total Assets | 83.96% |
| Annual Growth Rate | 14.31% |
| 5-Year Change | -12.75% |
| 10-Year Change | 71.55% |
| Growth Volatility | 67.43 |
JHS Svendgaard Laboratories Limited - Net Assets Trend (2006–2025)
This chart illustrates how JHS Svendgaard Laboratories Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for JHS Svendgaard Laboratories Limited (2006–2025)
The table below shows the annual net assets of JHS Svendgaard Laboratories Limited from 2006 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹1.73 Billion | +1.67% |
| 2024-03-31 | ₹1.70 Billion | -2.28% |
| 2023-03-31 | ₹1.74 Billion | -10.87% |
| 2022-03-31 | ₹1.95 Billion | -1.47% |
| 2021-03-31 | ₹1.98 Billion | +7.24% |
| 2020-03-31 | ₹1.85 Billion | +2.19% |
| 2019-03-31 | ₹1.81 Billion | +3.72% |
| 2018-03-31 | ₹1.74 Billion | +29.66% |
| 2017-03-31 | ₹1.34 Billion | +33.40% |
| 2016-03-31 | ₹1.01 Billion | -15.94% |
| 2015-03-31 | ₹1.20 Billion | +92.81% |
| 2014-03-31 | ₹621.24 Million | -30.37% |
| 2013-03-31 | ₹892.20 Million | -22.21% |
| 2012-03-31 | ₹1.15 Billion | +35.60% |
| 2011-03-31 | ₹845.82 Million | +14.51% |
| 2010-03-31 | ₹738.65 Million | +22.57% |
| 2009-03-31 | ₹602.66 Million | +2.28% |
| 2008-03-31 | ₹589.19 Million | +11.60% |
| 2007-03-31 | ₹527.97 Million | +288.15% |
| 2006-03-31 | ₹136.02 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to JHS Svendgaard Laboratories Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 35674800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₹856.04 Million | 49.56% |
| Other Components | ₹1.23 Billion | 71.09% |
| Total Equity | ₹1.73 Billion | 100.00% |
JHS Svendgaard Laboratories Limited Competitors by Market Cap
The table below lists competitors of JHS Svendgaard Laboratories Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PT Ecocare Indo Pasifik Tbk
JK:HYGN
|
$4.39 Million |
|
Energy Focu
NASDAQ:EFOI
|
$4.39 Million |
|
Classover Holdings, Inc. Class B Common Stock
NASDAQ:KIDZ
|
$4.40 Million |
|
Environmmtl Tectonic
PINK:ETCC
|
$4.40 Million |
|
Organoclick AB
ST:ORGC
|
$4.39 Million |
|
Han Kook Steel
KO:025890
|
$4.39 Million |
|
Grid Metals Corp
OTCQB:MSMGF
|
$4.39 Million |
|
Decade Resources Ltd
PINK:DECXF
|
$4.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in JHS Svendgaard Laboratories Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,698,840,000 to 1,727,272,000, a change of 28,432,000 (1.7%).
- Net loss of 197,443,000 reduced equity.
- Share repurchases of 225,000,000 reduced equity.
- New share issuances of 225,000,000 increased equity.
- Other comprehensive income increased equity by 29,362,000.
- Other factors increased equity by 196,513,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹-197.44 Million | -11.43% |
| Share Repurchases | ₹225.00 Million | -13.03% |
| Share Issuances | ₹225.00 Million | +13.03% |
| Other Comprehensive Income | ₹29.36 Million | +1.7% |
| Other Changes | ₹196.51 Million | +11.38% |
| Total Change | ₹- | 1.67% |
Book Value vs Market Value Analysis
This analysis compares JHS Svendgaard Laboratories Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.40x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.75x to 0.40x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-03-31 | ₹10.88 | ₹8.20 | x |
| 2007-03-31 | ₹59.55 | ₹8.20 | x |
| 2008-03-31 | ₹47.09 | ₹8.20 | x |
| 2009-03-31 | ₹46.13 | ₹8.20 | x |
| 2010-03-31 | ₹51.12 | ₹8.20 | x |
| 2011-03-31 | ₹58.27 | ₹8.20 | x |
| 2012-03-31 | ₹67.74 | ₹8.20 | x |
| 2013-03-31 | ₹37.12 | ₹8.20 | x |
| 2014-03-31 | ₹25.77 | ₹8.20 | x |
| 2015-03-31 | ₹49.71 | ₹8.20 | x |
| 2016-03-31 | ₹39.20 | ₹8.20 | x |
| 2017-03-31 | ₹22.62 | ₹8.20 | x |
| 2018-03-31 | ₹28.61 | ₹8.20 | x |
| 2019-03-31 | ₹29.04 | ₹8.20 | x |
| 2020-03-31 | ₹29.23 | ₹8.20 | x |
| 2021-03-31 | ₹30.61 | ₹8.20 | x |
| 2022-03-31 | ₹28.90 | ₹8.20 | x |
| 2023-03-31 | ₹22.17 | ₹8.20 | x |
| 2024-03-31 | ₹21.67 | ₹8.20 | x |
| 2025-03-31 | ₹20.73 | ₹8.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently JHS Svendgaard Laboratories Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -11.43%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -21.46%
- • Asset Turnover: 0.46x
- • Equity Multiplier: 1.16x
- Recent ROE (-11.43%) is below the historical average (-0.69%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 29.61% | 13.93% | 1.06x | 2.00x | ₹26.67 Million |
| 2007 | 8.28% | 13.73% | 0.46x | 1.31x | ₹-9.06 Million |
| 2008 | 6.03% | 9.76% | 0.35x | 1.76x | ₹-23.39 Million |
| 2009 | 2.30% | 4.94% | 0.24x | 1.91x | ₹-46.40 Million |
| 2010 | 10.86% | 11.72% | 0.48x | 1.93x | ₹6.38 Million |
| 2011 | 14.44% | 9.56% | 0.81x | 1.85x | ₹37.52 Million |
| 2012 | 0.97% | 0.88% | 0.54x | 2.03x | ₹-103.59 Million |
| 2013 | -4.21% | -6.31% | 0.26x | 2.59x | ₹-127.05 Million |
| 2014 | -46.39% | -81.85% | 0.19x | 3.05x | ₹-350.20 Million |
| 2015 | -18.51% | -40.09% | 0.33x | 1.42x | ₹-341.55 Million |
| 2016 | -21.49% | -21.62% | 0.83x | 1.20x | ₹-317.10 Million |
| 2017 | 16.33% | 20.80% | 0.68x | 1.16x | ₹85.00 Million |
| 2018 | 15.01% | 18.82% | 0.67x | 1.19x | ₹87.23 Million |
| 2019 | -0.38% | -0.55% | 0.56x | 1.25x | ₹-183.65 Million |
| 2020 | -1.11% | -1.43% | 0.57x | 1.35x | ₹-197.79 Million |
| 2021 | 0.63% | 1.20% | 0.44x | 1.21x | ₹-176.71 Million |
| 2022 | -2.18% | -4.74% | 0.39x | 1.19x | ₹-226.42 Million |
| 2023 | -10.08% | -20.83% | 0.37x | 1.31x | ₹-349.01 Million |
| 2024 | -2.39% | -5.81% | 0.35x | 1.16x | ₹-210.46 Million |
| 2025 | -11.43% | -21.46% | 0.46x | 1.16x | ₹-370.17 Million |
Industry Comparison
This section compares JHS Svendgaard Laboratories Limited's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $29,878,368,419
- Average return on equity (ROE) among peers: 18.88%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| JHS Svendgaard Laboratories Limited (JHS) | ₹1.74 Billion | 29.61% | 0.19x | $4.39 Million |
| Ambica Agarbathies & Aroma industries Limited (AMBICAAGAR) | $285.82 Million | 5.48% | 1.87x | $1.41 Million |
| Bajaj Consumer Care Limited (BAJAJCON) | $7.48 Billion | 16.75% | 0.20x | $292.15 Million |
| Cupid Limited (CUPID) | $759.35 Million | 20.03% | 0.22x | $67.40 Million |
| Dabur India Limited (DABUR) | $103.03 Billion | 17.88% | 0.47x | $3.08 Billion |
| Emami Limited (EMAMILTD) | $20.14 Billion | 15.25% | 0.39x | $936.77 Million |
| Godrej Consumer Products Limited (GODREJCP) | $94.39 Billion | 18.23% | 0.51x | $4.36 Billion |
| Hindustan Unilever Limited (HINDUNILVR) | $21.73 Billion | 62.51% | 2.08x | $25.41 Billion |
| Honasa Consumer Limited (HONASA) | $7.06 Billion | 2.23% | 0.47x | $447.54 Million |
| Jyothy Labs Limited (JYOTHYLAB) | $14.03 Billion | 11.55% | 0.44x | $278.06 Million |